However, another study using microRNA-based TREX1-knockdown successfully demonstrated tumor regression in vivo (89), and in two additional studies it was shown that microRNA-based TREX1-knockdown generates an IFN signature in uninfected wild-type cells [see control data in refs (90, 91)]. This evidence concerns the gene TREX1 and neoplasm.